JANX logo

Janux Therapeutics, Inc. (JANX) Free cash flow

annual FCF:

-$44.17M+$8.25M(+15.74%)
December 31, 2024

Summary

  • As of today (September 15, 2025), JANX annual free cash flow is -$44.17 million, with the most recent change of +$8.25 million (+15.74%) on December 31, 2024.
  • During the last 3 years, JANX annual FCF has fallen by -$25.71 million (-139.32%).
  • JANX annual FCF is now -1053.94% below its all-time high of -$3.83 million, reached on December 31, 2019.

Performance

JANX Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJANXcash flow metrics

quarterly FCF:

-$24.29M-$6.89M(-39.61%)
June 30, 2025

Summary

  • As of today (September 15, 2025), JANX quarterly free cash flow is -$24.29 million, with the most recent change of -$6.89 million (-39.61%) on June 30, 2025.
  • Over the past year, JANX quarterly FCF has dropped by -$14.17 million (-140.08%).
  • JANX quarterly FCF is now -548.91% below its all-time high of $5.41 million, reached on March 31, 2021.

Performance

JANX quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJANXcash flow metrics

TTM FCF:

-$60.70M-$14.17M(-30.45%)
June 30, 2025

Summary

  • As of today (September 15, 2025), JANX TTM free cash flow is -$60.70 million, with the most recent change of -$14.17 million (-30.45%) on June 30, 2025.
  • Over the past year, JANX TTM FCF has dropped by -$12.96 million (-27.14%).
  • JANX TTM FCF is now -3266.61% below its all-time high of $1.92 million, reached on March 31, 2021.

Performance

JANX TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJANXcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

JANX Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+15.7%-140.1%-27.1%
3 y3 years-139.3%-248.4%-63.9%
5 y5 years-1053.9%-3009.6%-3563.5%

JANX Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-139.3%+15.7%-976.5%at low-63.9%at low
5 y5-year-1053.9%+15.7%-548.9%at low-3266.6%at low
alltimeall time-1053.9%+15.7%-548.9%at low-3266.6%at low

JANX Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$24.29M(+39.6%)
-$60.70M(+30.5%)
Mar 2025
-
-$17.39M(+3.7%)
-$46.53M(+5.3%)
Dec 2024
-$44.17M(-15.7%)
-$16.77M(+643.2%)
-$44.17M(+16.8%)
Sep 2024
-
-$2.26M(-77.7%)
-$37.82M(-20.8%)
Jun 2024
-
-$10.12M(-32.7%)
-$47.74M(-10.4%)
Mar 2024
-
-$15.03M(+44.3%)
-$53.26M(+1.6%)
Dec 2023
-$52.42M(+6.2%)
-$10.42M(-14.5%)
-$52.42M(-6.3%)
Sep 2023
-
-$12.18M(-22.1%)
-$55.98M(-6.3%)
Jun 2023
-
-$15.63M(+10.1%)
-$59.73M(+17.0%)
Mar 2023
-
-$14.20M(+1.6%)
-$51.07M(+3.4%)
Dec 2022
-$49.37M
-$13.97M(-12.3%)
-$49.37M(+4.9%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$15.93M(+128.6%)
-$47.05M(+27.0%)
Jun 2022
-
-$6.97M(-44.2%)
-$37.05M(+1.9%)
Mar 2022
-
-$12.49M(+7.2%)
-$36.36M(+97.0%)
Dec 2021
-$18.46M(+322.5%)
-$11.65M(+96.5%)
-$18.46M(+118.9%)
Sep 2021
-
-$5.93M(-5.6%)
-$8.43M(+135.2%)
Jun 2021
-
-$6.28M(-216.1%)
-$3.58M(-287.0%)
Mar 2021
-
$5.41M(-432.1%)
$1.92M(-143.9%)
Dec 2020
-$4.37M(+14.1%)
-$1.63M(+50.4%)
-$4.37M(+59.5%)
Sep 2020
-
-$1.08M(+38.7%)
-$2.74M(+65.4%)
Jun 2020
-
-$781.00K(-10.8%)
-$1.66M(+89.2%)
Mar 2020
-
-$876.00K
-$876.00K
Dec 2019
-$3.83M
-
-

FAQ

  • What is Janux Therapeutics, Inc. annual free cash flow?
  • What is the all time high annual FCF for Janux Therapeutics, Inc.?
  • What is Janux Therapeutics, Inc. annual FCF year-on-year change?
  • What is Janux Therapeutics, Inc. quarterly free cash flow?
  • What is the all time high quarterly FCF for Janux Therapeutics, Inc.?
  • What is Janux Therapeutics, Inc. quarterly FCF year-on-year change?
  • What is Janux Therapeutics, Inc. TTM free cash flow?
  • What is the all time high TTM FCF for Janux Therapeutics, Inc.?
  • What is Janux Therapeutics, Inc. TTM FCF year-on-year change?

What is Janux Therapeutics, Inc. annual free cash flow?

The current annual FCF of JANX is -$44.17M

What is the all time high annual FCF for Janux Therapeutics, Inc.?

Janux Therapeutics, Inc. all-time high annual free cash flow is -$3.83M

What is Janux Therapeutics, Inc. annual FCF year-on-year change?

Over the past year, JANX annual free cash flow has changed by +$8.25M (+15.74%)

What is Janux Therapeutics, Inc. quarterly free cash flow?

The current quarterly FCF of JANX is -$24.29M

What is the all time high quarterly FCF for Janux Therapeutics, Inc.?

Janux Therapeutics, Inc. all-time high quarterly free cash flow is $5.41M

What is Janux Therapeutics, Inc. quarterly FCF year-on-year change?

Over the past year, JANX quarterly free cash flow has changed by -$14.17M (-140.08%)

What is Janux Therapeutics, Inc. TTM free cash flow?

The current TTM FCF of JANX is -$60.70M

What is the all time high TTM FCF for Janux Therapeutics, Inc.?

Janux Therapeutics, Inc. all-time high TTM free cash flow is $1.92M

What is Janux Therapeutics, Inc. TTM FCF year-on-year change?

Over the past year, JANX TTM free cash flow has changed by -$12.96M (-27.14%)
On this page